Want to join the conversation?
$CELG's sales from Otezla for 3Q15 increased by $121.1MM from last year, reflecting net sales of $128.4MM in the U.S. and $10.3MM in international markets. Sales from Abraxane rose by 8.3%, primarily due to increased unit volumes in international markets.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th